Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Tianci Han"'
Publikováno v:
Cell Death Discovery, Vol 7, Iss 1, Pp 1-9 (2021)
Abstract N6-methyladenosine (m6A) modification has been convincingly identified to be a critical regulator in human cancer. However, the contribution of m6A to NSCLC gefitinib resistance is still largely unknown. Here, we screened and identified that
Externí odkaz:
https://doaj.org/article/5bf3a14daf154bf9be5dbcbdb73d3b84
Publikováno v:
Arabian Journal of Chemistry, Vol 15, Iss 5, Pp 103722- (2022)
Cyclin D1 has been shown to play a pivotal role in the proliferation of lung cancer cells through regulation of cell cycle progression. Therefore, targeting this protein can be used as a potential strategy in lung cancer treatment. Calycosin has been
Externí odkaz:
https://doaj.org/article/ff6c78441a5642a9aeb92d357d7bf440
Publikováno v:
Cell Death Discovery, Vol 7, Iss 1, Pp 1-9 (2021)
Cell Death Discovery
Cell Death Discovery
N6-methyladenosine (m6A) modification has been convincingly identified to be a critical regulator in human cancer. However, the contribution of m6A to NSCLC gefitinib resistance is still largely unknown. Here, we screened and identified that m6A meth
Publikováno v:
Journal of B.U.ON. : official journal of the Balkan Union of Oncology. 24(6)
To explore the clinical efficacy of recombinant human endostatin combined with apatinib mesylate in patients with middle and advanced non-small cell lung cancer (NSCLC).A total of 64 patients with middle and advanced NSCLC were randomly divided into
Publikováno v:
OncoTargets and therapy
Wei Wang,1 Tianci Han,1 Wei Tong,1 Jian Zhao,1 Xueshan Qiu2 1Department of Thoracic Surgery, Cancer Hospital of China Medical University, Liaoning Cancer Hospital and Institute, Shenyang 110042, China; 2Department of Pathology, The First Hospital of
Autor:
TIANCI HAN1, TIANCI SHU2, SIYUAN DONG1, PEIWEN LI1, WEINAN LI3, DALI LIU3, RUIQUN QI2, SHUGUANG ZHANG1 shgzhang@mail.cmu.edu.cn, LIN ZHANG1 cmu_zhanglin@aliyun.com
Publikováno v:
Oncology Letters. May2017, Vol. 13 Issue 5, p2982-2988. 7p.
Autor:
Weinan Li, Tianci Shu, Dali Liu, Shuguang Zhang, Lin Zhang, Siyuan Dong, Ruiqun Qi, Tianci Han, Peiwen Li
Publikováno v:
Oncology Letters
Decreased expression of human chemokine-like factor-like MARVEL transmembrane domain-containing 3 (CMTM3) has been identified in a number of human tumors and tumor cell lines, including gastric and testicular cancer, and PC3, CAL27 and Tca-83 cell li
Autor:
TIANCI HAN, ZHIYONG WANG, YANG YANG, TIANCI SHU, WEINAN LI, DALI LIU, PEIWEN LI, RUIQUN QI, YI REN, LI LI, HONG LIU, SHUGUANG ZHANG, LIN ZHANG
Publikováno v:
Oncology Reports; 2015, Vol. 34 Issue 3, p1353-1360, 8p